Agrigenomics Market Report
RA02079
Agrigenomics Market , by Service (Genotyping, DNA Fingerprinting, Assessment Of Genetic Purity, Trait Purity Assessment, Gene Expression Analysis, Others), Application (Crops, Livestock), Technology (Real-Time PCR (qPCR), Microarrays, Next Generation Sequencing, Capillary Electrophoresis, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global agrigenomics market
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Agrigenomics Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Agrigenomics Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Agrigenomics Market , By Application
5.1. Overview
5.2 Genotyping
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 DNA Fingerprinting
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Assessment Of Genetic Purity
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Trait Purity Assessment
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Gene Expression Analysis
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Others
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Research Dive Exclusive Insights
5.8.1 Market attractiveness
5.8.2 Competition heatmap
-
6. Agrigenomics Market , By Device Type
6.1. Overview
6.2 Crops
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Livestock
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Agrigenomics Market , By Type Of Vaccine
7.1. Overview
7.2 Real-Time PCR (qPCR)
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Microarrays
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Next Generation Sequencing
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Capillary Electrophoresis
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Others
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
8. Agrigenomics Market , By Region
8.1 North America
8.1.1 U.S
8.1.1.1 Market size analysis, By Application, 2020-2027
8.1.1.2 Market size analysis, By Device Type, 2020-2027
8.1.1.3 Market size analysis, By Type of Vaccine, 2020-2027
8.1.2 Canada
8.1.2.1 Market size analysis, By Application, 2020-2027
8.1.2.2 Market size analysis, By Device Type, 2020-2027
8.1.2.3 Market size analysis, By Type of Vaccine, 2020-2027
8.1.3 Mexico
8.1.3.1 Market size analysis, By Application, 2020-2027
8.1.3.2 Market size analysis, By Device Type, 2020-2027
8.1.3.3 Market size analysis, By Type of Vaccine, 2020-2027
8.1.4 Research Dive Exclusive Insights
8.1.4.1 Market attractiveness
8.1.4.2 Competition heatmap
8.2 Europe
8.2.1 Germany
8.2.1.1 Market size analysis, By Application, 2020-2027
8.2.1.2 Market size analysis, By Device Type, 2020-2027
8.2.1.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.2 UK
8.2.2.1 Market size analysis, By Application, 2020-2027
8.2.2.2 Market size analysis, By Device Type, 2020-2027
8.2.2.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.3 France
8.2.3.1 Market size analysis, By Application, 2020-2027
8.2.3.2 Market size analysis, By Device Type, 2020-2027
8.2.3.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.4 Spain
8.2.4.1 Market size analysis, By Application, 2020-2027
8.2.4.2 Market size analysis, By Device Type, 2020-2027
8.2.4.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.5 Italy
8.2.5.1 Market size analysis, By Application, 2020-2027
8.2.5.2 Market size analysis, By Device Type, 2020-2027
8.2.5.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.6 Rest of Europe
8.2.6.1 Market size analysis, By Application, 2020-2027
8.2.6.2 Market size analysis, By Device Type, 2020-2027
8.2.6.3 Market size analysis, By Type of Vaccine, 2020-2027
8.2.7 Research Dive Exclusive Insights
8.2.7.1 Market attractiveness
8.2.7.2 Competition heatmap
8.3 Asia-Pacific
8.3.1 China
8.3.1.1 Market size analysis, By Application, 2020-2027
8.3.1.2 Market size analysis, By Device Type, 2020-2027
8.3.1.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.2 Japan
8.3.2.1 Market size analysis, By Application, 2020-2027
8.3.2.2 Market size analysis, By Device Type, 2020-2027
8.3.2.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.3 India
8.3.3.1 Market size analysis, By Application, 2020-2027
8.3.3.2 Market size analysis, By Device Type, 2020-2027
8.3.3.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.4 Australia
8.3.4.1 Market size analysis, By Application, 2020-2027
8.3.4.2 Market size analysis, By Device Type, 2020-2027
8.3.4.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.5 South Korea
8.3.5.1 Market size analysis, By Application, 2020-2027
8.3.5.2 Market size analysis, By Device Type, 2020-2027
8.3.5.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.6 Rest of Asia-Pacific
8.3.6.1 Market size analysis, By Application, 2020-2027
8.3.6.2 Market size analysis, By Device Type, 2020-2027
8.3.6.3 Market size analysis, By Type of Vaccine, 2020-2027
8.3.7 Research Dive Exclusive Insights
8.3.7.1 Market attractiveness
8.3.7.2 Competition heatmap
8.4 LAMEA
8.4.1 Brazil
8.4.1.1 Market size analysis, By Application, 2020-2027
8.4.1.2 Market size analysis, By Device Type, 2020-2027
8.4.1.3 Market size analysis, By Type of Vaccine, 2020-2027
8.4.2 Saudi Arabia
8.4.2.1 Market size analysis, By Application, 2020-2027
8.4.2.2 Market size analysis, By Device Type, 2020-2027
8.4.2.3 Market size analysis, By Type of Vaccine, 2020-2027
8.4.3 UAE
8.4.3.1 Market size analysis, By Application, 2020-2027
8.4.3.2 Market size analysis, By Device Type, 2020-2027
8.4.3.3 Market size analysis, By Type of Vaccine, 2020-2027
8.4.4 South Africa
8.4.4.1 Market size analysis, By Application, 2020-2027
8.4.4.2 Market size analysis, By Device Type, 2020-2027
8.4.4.3 Market size analysis, By Type of Vaccine, 2020-2027
8.4.5 Rest of LAMEA
8.4.5.1 Market size analysis, By Application, 2020-2027
8.4.5.2 Market size analysis, By Device Type, 2020-2027
8.4.5.3 Market size analysis, By Type of Vaccine, 2020-2027
8.4.6 Research Dive Exclusive Insights
8.4.6.1 Market attractiveness
8.4.6.2 Competition heatmap
9. Competitive Landscape
9.1 Top winning strategies, 2020-2027
9.1.1 By strategy
9.1.2 By year
9.2 Strategic overview
9.3 Market share analysis, 2020-2027
10. Company Profiles
10.1 Eurofins Scientific Se
10.1.1 Overview
10.1.2 Business segments
10.1.3 Product portfolio
10.1.4 Financial performance
10.1.5 Recent developments
10.1.6 SWOT analysis
10.2 Thermo Fisher Scientific' Inc
10.2.1 Overview
10.2.2 Business segments
10.2.3 Product portfolio
10.2.4 Financial performance
10.2.5 Recent developments
10.2.6 SWOT analysis
10.3 Illumina' Inc.
10.3.1 Overview
10.3.2 Business segments
10.3.3 Product portfolio
10.3.4 Financial performance
10.3.5 Recent developments
10.3.6 SWOT analysis
10.4 Zoetis' Inc. Neogen Corporation
10.4.1 Overview
10.4.2 Business segments
10.4.3 Product portfolio
10.4.4 Financial performance
10.4.5 Recent developments
10.4.6 SWOT analysis
10.5 Galseq Srl Via Italia
10.5.1 Overview
10.5.2 Business segments
10.5.3 Product portfolio
10.5.4 Financial performance
10.5.5 Recent developments
10.5.6 SWOT analysis
10.6 Agrigenomics' Inc.
10.6.1 Overview
10.6.2 Business segments
10.6.3 Product portfolio
10.6.4 Financial performance
10.6.5 Recent developments
10.6.6 SWOT analysis
10.7 Biogenetic Services' Inc.
10.7.1 Overview
10.7.2 Business segments
10.7.3 Product portfolio
10.7.4 Financial performance
10.7.5 Recent developments
10.7.6 SWOT analysis
10.8 Arbor Biosciences
10.8.1 Overview
10.8.2 Business segments
10.8.3 Product portfolio
10.8.4 Financial performance
10.8.5 Recent developments
10.8.6 SWOT analysis
10.9 Tecan Genomics, Inc.
10.9.1 Overview
10.9.2 Business segments
10.9.3 Product portfolio
10.9.4 Financial performance
10.9.5 Recent developments
10.9.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com